O'Dell Group, LLC Amgen Inc Transaction History

O'Dell Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $119,156 - $134,422	466 New	466 $134,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $97,492 - $115,283	455 New	455 $101,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $673 - $759	3 Added 0.76%	399 $90,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $34,606 - $38,511	-150 Reduced 27.47%	396 $96,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $4,823 - $5,336	-22 Reduced 3.87%	546 $132,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $994 - $1,138	5 Added 0.89%	568 $128,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $119,508 - $140,018	563 New	563 $120,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $227,071 - $301,158	-1,246 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $2,838 - $3,648	-15 Reduced 1.19%	1,246 $300,000
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $5,223 - $6,258	30 Added 2.44%	1,261 $244,000
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $26,171 - $30,679	157 Added 14.62%	1,231 $227,000
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $194,254 - $218,967	1,074 New	1,074 $204,000

3,121

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.